Clinical stage biotechnology company Fore Biotherapeutics has appointed Matthew E. Ros as Chief Executive Officer and Director of the Board.
Prior to joining Fore, Ros was Executive Vice President and Chief Strategy and Business Officer of Epizyme, Inc., a commercial-stage and publicly traded biopharmaceutical company developing novel epigenetic therapies.
Ros has held leadership positions across sales, marketing, franchise strategy and business operations, having began his career in the Oncology division at Bristol Myers Squibb.
Dieter Weinand, the Chairman of the Board of Directors commented:
“After an extensive search, we are delighted and very excited to welcome Matt as our next CEO. Matt brings enormous experience to grow and scale Fore as an innovative biotech given his track record of success in both mature and emerging life sciences companies.
“He is the right leader for our company, and the Board and I are delighted to partner with Matt to navigate Fore’s path to continued success.”
“I am honoured and humbled to lead Fore and work alongside the incredibly talented management team to build upon what has been accomplished to date.
“Fore is poised to develop targeted treatments that fundamentally transform the way cancer is treated. The company’s functional genomics platform provides us with the opportunity to serve cancer patients with novel, innovative medicines.”
Fore focuses on hyper-targeting precision oncology therapies for patients with unaddressed tumour mutations.
The Company expects to complete enrolment to its Phase 1/2a study in the coming months, and to launch a registrational Phase 2 study of its clinical Class I/II BRAF inhibitor, FORE8394.
FORE8394 has demonstrated clinical safety and early efficacy signals in an ongoing Phase 1/2a clinical trial.
Digital twins set to advance stroke care
Can AI help keep the human experience in social care?
mRNA discovery paves the way to safer vaccines
Eye scans provide crucial insights into kidney health
Key tips for accelerating the health security compliance journey
Nordic Consulting strengthens team in Ireland
Healthcare innovators and leaders honoured at Imprivata HealthCon user group and awards ceremony
Wearable communication system may reduce digital health divide
Molecule trains the immune system to prevent cancer
Diabetes patients urged to use fitness games with caution
- Medtech3 weeks ago
UK student team wins world Heart Hackathon competition
- Interviews1 week ago
Photodisinfectant: can light curb the antimicrobial resistance crisis?
- News3 weeks ago
Where next for the shared care record (or the connected care record)?
- News1 week ago
Listen: Longevity, Eastern wisdom and Western science